SCHEMBL5815917

SCHEMBL5815917

Cc1nc(-c2ccccc2)c(NC(=O)NS(=O)(=O)c2ccc(Cl)cc2)s1

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 8/20 0.65
KDM4E B2RXH2 2/20 0.51
GAA P10253 1/20 0.49
MAPT P10636 1/20 0.49
PTGDR2 Q9Y5Y4 1/20 0.46
PTGS1 P23219 4/20 0.46
PTGS2 P35354 4/20 0.46
LMNA P02545 1/20 0.46
ALDH1A1 P00352 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
FLT1 P17948 2/20 0.45
FLT4 P35916 2/20 0.45
KDR P35968 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
TASP1 Q9H6P5 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8259565 0.86 KDM4E (0.48) NTRK1KDM4EGAAMAPTPTGS1
SCHEMBL8260616 0.86 KDM4E (0.48) NTRK1KDM4EGAAMAPTPTGS1
SCHEMBL8252821 0.85 NTRK1 (0.60) NTRK1GAAPTGS2LMNAALDH1A1
SCHEMBL8260573 0.85 CYP2C9 (0.47) NTRK1KDM4EGAAMAPTPTGS1
SCHEMBL5819206 0.83 ALDH1A1 (0.49) NTRK1KDM4EGAAMAPTPTGS1
SCHEMBL8260918 0.83 KDM4E (0.45) NTRK1KDM4EGAAMAPTPTGDR2
SCHEMBL5819647 0.83 KDM4E (0.45) NTRK1KDM4EGAAMAPTPTGDR2
SCHEMBL5820018 0.82 NTRK1 (0.54) NTRK1KDM4EGAAMAPTPTGDR2
SCHEMBL5819644 0.82 KDM4E (0.44) NTRK1KDM4EGAAMAPTPTGDR2
SCHEMBL5819740 0.81 KDM4E (0.43) NTRK1KDM4EGAAMAPTPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006085815-A1 THIAZOLE DERIVATIVES, THEIR PROCESS FOR THEIR PREPARATION AND THEIR USE IN THERAPY ASTRAZENECA AB (SE) 2006-08-17 WO disclosed
WO-2006085815-A1 THIAZOLE DERIVATIVES, THEIR PROCESS FOR THEIR PREPARATION AND THEIR USE IN THERAPY ASTRAZENECA AB (SE) 2006-08-17 WO disclosed